These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36210812)

  • 21. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho preservation via histone deacetylase inhibition attenuates chronic kidney disease-associated bone injury in mice.
    Lin W; Li Y; Chen F; Yin S; Liu Z; Cao W
    Sci Rep; 2017 Apr; 7():46195. PubMed ID: 28387374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working group.
    Kanbay M; Copur S; Ozbek L; Mutlu A; Cejka D; Ciceri P; Cozzolino M; Haarhaus ML
    Clin Kidney J; 2024 Jan; 17(1):sfad276. PubMed ID: 38213484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2014; 86(4):36-44. PubMed ID: 24864466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between Soluble
    Wang Q; Su W; Shen Z; Wang R
    Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
    BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism.
    Liu J; Wang H; Liu Q; Long S; Wu Y; Wang N; Lin W; Chen G; Lin M; Wen J
    Cell Biosci; 2024 Apr; 14(1):46. PubMed ID: 38584258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 2: Pathophysiology of calcium disorder and extraosseous calcification.
    Tang PK; Geddes RF; Jepson RE; Elliott J
    Vet J; 2021 Sep; 275():105718. PubMed ID: 34329743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum α-Klotho Protein Can Be an Independent Predictive Marker of Oxidative Stress (OS) and Declining Glomerular Function Rate in Chronic Kidney Disease (CKD) Patients.
    Jena S; Sarangi P; Das UK; Lamare AA; Rattan R
    Cureus; 2022 Jun; 14(6):e25759. PubMed ID: 35812534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Holden RM; Mustafa RA; Alexander RT; Battistella M; Bevilacqua MU; Knoll G; Mac-Way F; Reslerova M; Wald R; Acott PD; Feltmate P; Grill A; Jindal KK; Karsanji M; Kiberd BA; Mahdavi S; McCarron K; Molnar AO; Pinsk M; Rodd C; Soroka SD; Vinson AJ; Zimmerman D; Clase CM
    Can J Kidney Health Dis; 2020; 7():2054358120944271. PubMed ID: 32821415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of Klotho in clinical nephrology.
    Hu MC; Kuro-o M; Moe OW
    Nephrol Dial Transplant; 2012 Jul; 27(7):2650-7. PubMed ID: 22802580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis.
    Thongprayoon C; Neyra JA; Hansrivijit P; Medaura J; Leeaphorn N; Davis PW; Kaewput W; Bathini T; Salim SA; Chewcharat A; Aeddula NR; Vallabhajosyula S; Mao MA; Cheungpasitporn W
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease.
    Donate-Correa J; Ferri CM; Martín-Núñez E; Pérez-Delgado N; González-Luis A; Mora-Fernández C; Navarro-González JF
    Sci Rep; 2021 Aug; 11(1):15877. PubMed ID: 34354161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of controlling phosphorus in chronic kidney disease.
    Cannata-Andía JB; Martin KJ
    Nephrol Dial Transplant; 2016 Apr; 31(4):541-7. PubMed ID: 25770169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors for anemia in the early stages of chronic kidney disease].
    Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
    Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.